Tong Ren Tang Technologies Co. Ltd.

HKSE 1666.HK

Tong Ren Tang Technologies Co. Ltd. Price to Sales Ratio (P/S) on January 28, 2025: 0.84

Tong Ren Tang Technologies Co. Ltd. Price to Sales Ratio (P/S) is 0.84 on January 28, 2025, a -18.42% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Tong Ren Tang Technologies Co. Ltd. 52-week high Price to Sales Ratio (P/S) is 1.14 on October 07, 2024, which is 35.66% above the current Price to Sales Ratio (P/S).
  • Tong Ren Tang Technologies Co. Ltd. 52-week low Price to Sales Ratio (P/S) is 0.81 on April 19, 2024, which is -4.01% below the current Price to Sales Ratio (P/S).
  • Tong Ren Tang Technologies Co. Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 0.89.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
SV Wall Street
HKSE: 1666.HK

Tong Ren Tang Technologies Co. Ltd.

CEO Mr. Jia Fu Chen
IPO Date Oct. 31, 2000
Location China
Headquarters No. 20 Nansanhuan Zhonglu Road
Employees 4,005
Sector Healthcare
Industries
Description

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.

Similar companies

2005.HK

SSY Group Limited

USD 0.41

0.30%

1681.HK

Consun Pharmaceutical Group Limited

USD 1.01

0.62%

1515.HK

China Resources Medical Holdings Company Limited

USD 0.48

-1.60%

1513.HK

Livzon Pharmaceutical Group Inc.

USD 3.38

-0.40%

StockViz Staff

February 3, 2025

Any question? Send us an email